177 related articles for article (PubMed ID: 31024314)
1. Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats.
Balogh M; Zádor F; Zádori ZS; Shaqura M; Király K; Mohammadzadeh A; Varga B; Lázár B; Mousa SA; Hosztafi S; Riba P; Benyhe S; Gyires K; Schäfer M; Fürst S; Al-Khrasani M
Front Pharmacol; 2019; 10():347. PubMed ID: 31024314
[TBL] [Abstract][Full Text] [Related]
2. The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.
Balogh M; Zádori ZS; Lázár B; Karádi D; László S; Mousa SA; Hosztafi S; Zádor F; Riba P; Schäfer M; Fürst S; Al-Khrasani M
Neurochem Res; 2018 Jun; 43(6):1250-1257. PubMed ID: 29725918
[TBL] [Abstract][Full Text] [Related]
3. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
[TBL] [Abstract][Full Text] [Related]
4. A new potent analgesic agent with reduced liability to produce morphine tolerance.
Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M
Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542
[TBL] [Abstract][Full Text] [Related]
5. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M
Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777
[TBL] [Abstract][Full Text] [Related]
6. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
[TBL] [Abstract][Full Text] [Related]
7. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration.
Lackó E; Riba P; Giricz Z; Váradi A; Cornic L; Balogh M; Király K; Csekő K; Mousa SA; Hosztafi S; Schäfer M; Zádori ZS; Helyes Z; Ferdinandy P; Fürst S; Al-Khrasani M
J Pharmacol Exp Ther; 2016 Oct; 359(1):171-81. PubMed ID: 27435180
[TBL] [Abstract][Full Text] [Related]
8. Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor.
Shaqura M; Khalefa BI; Shakibaei M; Winkler J; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
J Pain; 2013 Jul; 14(7):720-30. PubMed ID: 23623572
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Dec; 99(6):1409-14. PubMed ID: 14639157
[TBL] [Abstract][Full Text] [Related]
10. Contribution of G-Protein α-Subunits to Analgesia, Hyperalgesia, and Hyperalgesic Priming Induced by Subanalgesic and Analgesic Doses of Fentanyl and Morphine.
Araldi D; Bonet IJM; Green PG; Levine JD
J Neurosci; 2022 Feb; 42(7):1196-1210. PubMed ID: 34965973
[TBL] [Abstract][Full Text] [Related]
11. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
12. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
13. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
[TBL] [Abstract][Full Text] [Related]
14. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
15. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats.
Zurek JR; Nadeson R; Goodchild CS
Pain; 2001 Feb; 90(1-2):57-63. PubMed ID: 11166970
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
[TBL] [Abstract][Full Text] [Related]
17. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
18. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
Wang D; Chen T; Zhou X; Couture R; Hong Y
Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
[TBL] [Abstract][Full Text] [Related]
19. 14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.
Zádor F; Balogh M; Váradi A; Zádori ZS; Király K; Szűcs E; Varga B; Lázár B; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
Eur J Pharmacol; 2017 Nov; 814():264-273. PubMed ID: 28864212
[TBL] [Abstract][Full Text] [Related]
20. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
